Other languages Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Delayed Canadian Securities Exchange Other stock markets 14:30:00 30/04/2024 BST			5-day change	1st Jan Change
0.165 ^CAD	-.--%		-17.50%	+65.00%

04-29	Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
04-18	Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2023	03-26
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	26/10/23
Entheon Biomedical Corp. Announces Termination of Andrew Hegle as Chief Science Officer	01/08/23
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	26/07/23
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2023	28/04/23
Entheon Biomedical Corp. Announces Termination of Consulting Agreement with Cybin	28/04/23
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	22/03/23
Entheon Biomedical Corp. Announces Resignation of Ruth Chun as Director	02/03/23
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	31/10/22
Entheon Biomedical Corp. Closes Patient Enrolment in its Clinical Research Study EBIQ-101	05/10/22
Entheon Biomedical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	26/07/22
Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 28, 2022	29/04/22
Entheon Biomedical Corp. Reports Earnings Results for the Full Year Ended November 30, 2021	30/03/22
Entheon Biomedical Corp. Auditor Raises 'Going Concern' Doubt	29/03/22
Entheon Biomedical Corp. Announces Enrollment in Phase 1 Study of DMT	15/03/22
Entheon Biomedical Corp. Announces EBIQ-101 First-Patient Dose	24/02/22
Entheon Biomedical Partners with Wavepaths on Upcoming Observational Study	16/02/22
Entheon Biomedical Corp. Announces the Approval of DMT Clinical Trial	03/02/22
Entheon Biomedical Corp. Announces the Submission of the Regulatory Package for Its Upcoming Phase 1 Clinical Trial	06/01/22
Entheon Biomedical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2021	29/10/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Other languages

Filters